# What the team did A research group led by Mikhail Shapiro published a study in iScience describing a new imaging approach that combines three ultrasound modes to monitor glioblastoma growth inside the living brain. They implanted engineered human glioblastoma cells into the left thalamus of mice and followed tumor progression over 11 days while the mice were awake but head-fixed on a cushioned platform.
# Why this matters Glioblastoma is an aggressive brain cancer with poor prognosis. Existing imaging methods each have trade-offs: MRI covers whole-brain structure but has limits for awake-behaving animals, optical imaging offers high detail but shallow depth, and no single method previously captured tumor growth, vascular remodeling, and neural hemodynamics together at comparable depth and resolution. The researchers designed an ultrasound protocol to capture all three in a co-registered acquisition.
# How trimodal ultrasound works The approach uses three co-registered ultrasound measurements:
- Hemodynamic imaging of blood volume associated with neural activity. This mode tracked changes in blood volume tied to visually evoked activity in the brain area near the tumor.
- Microbubble contrast to map the vasculature. Injected microbubbles allowed detailed mapping of blood vessels around the tumor.
Combining these modes gave spatially aligned views of tumor margin, vessel network, and activity-related blood flow.
# Key observations The trimodal images show tumor growth over 11 days alongside surrounding vessels and visually evoked activity. As the tumor expanded:
- It physically displaced the lateral geniculate nucleus (LGN), a thalamic structure involved in visual processing.
- Vascular structure around the tumor changed as it grew, visible via microbubble mapping.
# Experimental context and constraints
# What this technique could enable The method lets researchers observe, in vivo and without open surgery, how an aggressive brain tumor alters local tissue position, blood-vessel architecture, and activity-linked hemodynamics at once. That combined information may help reveal mechanisms by which glioblastoma co-opts neural tissue and blood supply, and it provides a platform for testing interventions that target tumor–vasculature interactions.
# Immediate takeaways for clinicians and researchers